Related Experiment Video
Updated: Aug 25, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Unraveling the NALP-3/IL-1beta inflammasome: a big lesson from a small mutation
1University Colorado Health Sciences Center, Division of Infectious Diseases, B168, 4200 East Ninth Avenue, Denver, CO 80262, USA.
Abstract:
Cytokine-mediated inflammation is a target for novel therapies as well as for fundamental research. A single amino acid mutation in the NALP-3 gene controlling the activation of caspase-1 results in increased processing of the inactive IL-1beta precursor and release of the active cytokine. Blocking IL-1 receptors arrests inflammation in humans with the mutation.
Insights
A mutation in the NALP-3 gene causes increased inflammatory cytokine release. Blocking interleukin-1 (IL-1) receptors effectively halts inflammation in affected individuals, offering a potential therapeutic target.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Cytokine-mediated inflammation is a key area for therapeutic development and basic research.
- The NALP-3 inflammasome plays a critical role in regulating inflammatory responses.
Purpose of the Study:
- To investigate the impact of a specific NALP-3 gene mutation on inflammatory pathways.
- To evaluate the efficacy of blocking interleukin-1 (IL-1) signaling in mitigating inflammation associated with this mutation.
Main Methods:
- Genetic analysis of the NALP-3 gene.
- Assay of caspase-1 activation and IL-1beta processing.
- Pharmacological blockade of IL-1 receptors.
Main Results:
- A single amino acid mutation in NALP-3 was identified.
- This mutation leads to enhanced processing of the inactive IL-1beta precursor.
- The release of active IL-1beta cytokine was significantly increased.
- Blocking IL-1 receptors successfully arrested inflammation in affected humans.
Conclusions:
- The NALP-3 gene mutation is directly linked to excessive IL-1beta production and inflammation.
- Targeting IL-1 receptors represents a viable therapeutic strategy for managing NALP-3-associated inflammatory conditions.
Related Concept Videos
Regulation of the Unfolded Protein Response
The Unfolded Protein Response
Mechanism of Lamellipodia Formation
Caspases
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Export of Misfolded Proteins out of the ER

